Downloading...
Download

Teladoc

Teladoc partners with Brightline to expand into paediatricTeladoc Health Inc., a leader in the US telemedicine market, has announced a strategic partnership with Brightline, a digital platform specialising in mental health care for children, adolescents, and their families. This partnership marks Teladoc's entry into a new and promising healthcare market segment, focusing on paediatric mental health – a critical area of growing need. Through this collaboration, Teladoc Health will integrate Brightline's expertise in paediatric psychology and psychiatry into its telemedicine service, offering access to specialised care for a sensitive and complex patient group. This move expands Teladoc's service range and positions it at the forefront of addressing the rising mental health challenges among younger populations. Technical analysis of Teladoc Health Inc. (NYSE: TDOC) Let us explore the potential trading opportunities based on the current technical setup of Teladoc's stock: Timeframe : Daily (D1) Current trend : the stock is showing signs of the beginning of an uptrend Resistance level : 10.15 USD Support level : 9.25 USD Potential downtrend target : if the stock enters a downtrend, the downside target could be around 8.70 USD Short-term target : if the uptrend continues and the stock breaches the resistance at 10.15 USD, a short-term target could be set at 11.85 USD Medium-term target : with sustained positive momentum, the stock price might rise to 13.40 USD Investors should closely monitor Teladoc Health's performance, particularly in light of this new partnership with Brightline. Integrating specialised paediatric mental health services could significantly enhance Teladoc's market position and potentially increase stock value as the company taps into this underserved sector. — Ideas and other content presented on this page should not be considered as guidance for trading or an investment advice. RoboMarkets bears no responsibility for trading results based on trading opinions described in these analytical reviews. The material presented and the information contained herein is for information purposes only and in no way should be considered as the provision of investment advice for the purposes of Investment Firms Law L. 87(I)/2017 of the Republic of Cyprus or any other form of personal advice or recommendation, which relates to certain types of transactions with certain types of financial instruments. Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65.68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
NYSE:TDOC
by RoboMarkets
TDOC Teladoc Health Options Ahead of EarningsIf you haven`t sold TDOC here: Then analyzing the options chain and chart patterns of TDOC Teladoc prior to the earnings report this week, I would consider purchasing the 20usd in the money strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $5.90. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NYSE:TDOCLong
by TopgOptions
2
TDOC - Teladoc bottom fishingHello. This chart is strictly a Technical Analysis of Teladoc (TDOC). I think currently we are in a point in TDOC's price action where we've reached a fundamental SUPPORT area if you look back to 2016. This could potentially be opportune BUY ZONE. TA is all about probability. The probability we go down is always there, just in this scenario i believe the probability of downside is less compared to the upside. Though i want some short term downside for TDOC, as i believe that would be the necessary catalyst to help shift trend to upside. Price will eventually rally up, especially if we are in a bull market currently. Which i believe we are in. Ill go into details on why i want it and believe this. NOTE: This is on the WEEKLY timeframe, so we are looking into a more macro scenario than if we were to look at DAILY timeframe. LAST WEEk -> We printed a candle that has a large upper wick, indicating SELLING pressure. We are also resting right on top of a major support level at around $23, indicated by green horizontal like. It wouldnt be bad for price to drop below and touch the lower 2 green lines, the sloping one and horizontal one. This would be a catalyst due to price action then, starting to confirm what is known as a BULLISH DIVERGENCE. Which is a pattern or concept where PRICE ACTION forms LOWER LOWS, as INDICATORS create HIGHER LOWERS -> Seen by the white sloping line drawn in the RSI and MACD. And the green sloping line in PRICE ACTION indicates the lower lows. *Many trades ive recently taken have followed similar patterns, ill link 1 chart to compare this to BELOW* Its for stock LMND. Heres also a SNAP SHOT. NOTICE the horizontal white line on RSI -> this is what helps me guage at when this move and UPSIDE can start or hit. If RSI breaks out above this line, we can start to see BULLISH DIVERGENCE playout. Easily i can see TDOC hitting around the $40.00 level. Going back to CURRENT price action. I believe we go down and test the lower green lines, because of all this RESISTANCE that we are facing. NOTICE: #PURPLE SLOPING RESISTANCE LINE -> This is MAJOR MAJOR resistance, created since Feb 2021. We just tested it for the 3rd time, last week. (Note: atleast 3 touches are required to weaken lines, more price touches lines -> the weaker they get.) # We also got some short term WHITE SLOPING RESISTANCE LINES. Helping to push price down # We also got the 21 EMA (YELLOW Moving average) ******Note, all these are meeting together to act as RESISTANCE. When theres so many converging, like this -> It gets a little hard or takes time to break through to upside. ***ALso i think the PURPLE line is MOST IMPORTANT. This would help reverse trend in a major macro way. SO KEEP OBSERVING. Lastly, note the ADX & DI -> This is a momentum indicator. When RED line is over Green line, it indicates BEARISH Price action, as you can see by the downtrend. Currently there is some green overlapping occuring. We have to keep observing to see how this progresses. But ideally, we'd like to see Green shoot up to above 20 level, just like the red line did in white box. CONCLUSION: I believe in the short term, we could have some downside price action coming. But sometimes, downside action could have positive ramifications. In this case, further strengthening the BULLISH DIVERGENCE forming in the charts. Indicators and current support area, indicate seller exhausting. Probabilities in my opinion point to price moving up than down. Hitting either one of the lower green support lines, could be areas where positions can be taken with stop losses set below. DISCLAIMER: This is by NO MEANS, Financial advice. I am not a financial advisor, im just a TA nerd and post these for educational purpose. Always follow your own due diligence when trading/investing. Always focus most of your energy on risk management strategies. If you like this content, please do BOOST, FOLLOW and do COMMENT, i would like others opinions on what your seeing, whether TA or FA. Thank you.
NYSE:TDOC
by SafofAllTrades
I need a TDOC-torTeladoc Health Short Term - We look to Sell at 32.97 (stop at 37.50) The medium term bias remains bearish. There is no indication that the selloff is coming to an end. There is scope for mild buying at the open but gains should be limited. Preferred trade is to sell into rallies. Our profit targets will be 21.64 and 15.19 Resistance: 35.00 / 59.00 / 78.00 Support: 28.50 / 20.00 / 10.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NYSE:TDOCShort
by Saxo
2
Teladoc Short and LongTeladoc is range bound atm. We might have this range for a long time. best trades are to long the low and short the top. We got a rejection from the POC of the range and are making our way down to the golden pocket, HVN and an orderblock. If we loose this level i am looking down to the bottom of the channel. As being in the channel we are also in a descending triangle type structure. Looking to see how this brakes also. No financial advice. Just sharing trade ideas. Cheers
NYSE:TDOC
by SeyBeats
TelaDoc Health (NYSE: $TDOC) Appears Massively Oversold! 🏥Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
NYSE:TDOCLong
by Bullishcharts
1
Teladoc Health (NYSE: $TDOC) Looking For A Rapid Reversal! 👨‍⚕️Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
NYSE:TDOCLong
by Bullishcharts
2
Teladoc (NYSE: $TDOC) Could See Epic Bounce As Omicron Spreads!Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
NYSE:TDOCLong
by Bullishcharts
6
$TDOCTeladoc Health's shares skyrocketed nearly 140% last year. So far in 2021, though, the stock is down close to 30%. The average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives TDOC stock a score of 29 out of a possible 100. That rank is mainly influenced by a short-term technical score of 10. TDOC's rank also includes a long-term technical score of 13. The fundamental score for TDOC is 65. In addition to the average rating from Wall Street analysts, TDOC stock has a mean target price of $208.88. This means analysts expect the stock to gain 48.25% over the next 12 months. I think TDOC is absolutely here to stay. Telehealth will grow, and beyond Telehealth, virtual care in general. Chronic disease management, I think it was a good acquisition for Teladoc. I thought it brought a good platform into its lineup, and there's a great opportunity for cross-selling there. - After a long battle to hold its price since late February TDOC had finally formed a falling wedge on the daily chart. It’s starting to look very clean here for a continuation up. A clean break on the falling wedge. RSI breaking above 50 & the MACD curling I suggest keeping this on your watchlist. - Factor Four
NYSE:TDOCLong
by TheBlankFund
Teladoc Trade [TDOC]A staple of Cathie Wood's ARKK Invest fund, Teladoc looks to be winding up for a big move in the coming days after breaking the resistance of a supply line that has kept TDOC stagnant since the peak of its small rally in June. Now we find it at a key support level just outside of the trendline and finding support on our 21 MA as well. I am long on TDOC with a stop loss at $149.99. At this point, if the green horizontal line of support would be broken, the next level we want to look at for a long would be $146.84. However, a break and close of $146 would be a break into my no trade zone. Bonus points for the asset if it can hold and maintain price action outside of our green, downward sloping line of resistance now hopefully flipped support.
NYSE:TDOCLong
by TradeVibez
Trading Idea - #TeladocSHORT against Cathie Wood! Time is too young for this innovation! :-) ENTRY: 152.20 USD TARGET1: 86.30 USD TARGET2: 58.90 USD (+61%) STOP: 208.30 USD Teladoc Health provides virtual healthcare services on a business-to-business (B2B) basis to its clients and provides services to consumers directly and through channel partners. The Company's consumer brands, including Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, provides access to advice and resolution to a range of healthcare needs. Its technology enables consumers to manage their own electronic medical records. It also provides access to a message center, provider finder, image upload capability and enable real-time sharing capabilities with providers that includes visit scheduling. Number of employees : 4 400 people. 1.) Teladoc broke through the short-term support area easily! Usual indicator to continue downward trend! 2.) Q1 Net Loss Expands as Sales Advance 3.) The largest stake in the Ark Genomic Revolution ETF is Teladoc Health. The company is the most heavily weighted stock in the fund at 7.44%. Teladoc rose to a record high earlier this year and has since fallen 34%.
NYSE:TDOCShort
by Traderherz-Analytics
5